HIVE Stock (TSXV:HIVE) — Boom or Bust?

HIVE Blockchain Technologies (TSX:HIVE)(NASDAQ:HVBT) is a cool company, but is HIVE stock worth a long-term investment?

| More on:

The cryptocurrency market created an offshoot of several companies for Motley Fool investors to consider. Some of these options indeed seemed safer given that Bitcoin and other currencies seemed to ebb and flow so radically. Instead of taking on risks, you could look for blockchain companies that mine cryptocurrency.

One such company is HIVE Blockchain Technologies (TSXV:HIVE)(NASDAQ:HVBT). Once a mineral miner, the company has since changed tactics to become a cryptocurrency mining company in Canada, Sweden, and Iceland, focusing mainly on Ethereum and Bitcoin. But given the volatile situation involved with cryptocurrency right now, perhaps it’s time to consider whether HIVE stock is a good option for your portfolio.

But first, what is blockchain mining?

Hey, we all have to start somewhere, and blockchain technologies are complicated. So before we dig into whether HIVE stock can make it, let’s see what it does in the first place.

Bitcoin mining is like the tech sector’s solution to the gold rush. Instead of camping out near a lake starving and getting trench foot, you can sit in front of your laptop and mine this way. But it’s not that simple. To find Bitcoin and others to put into circulation — as you would if you mined for gold — you have to perform incredibly difficult math problems on sophisticated computers.

Furthermore, similar to gold mining, mining for cryptocurrency companies like HIVE stock is costly and difficult. It takes forever, and you’re only rewarded sometimes. So while you may not get trench foot, you may end up with carpal tunnel syndrome. But still, if you’re one for puzzles on the computer, it may well be something you’ll want to look into if you haven’t already.

What about HIVE stock?

That’s why a company like HIVE stock is a good option. It digs for cryptocurrency so you don’t have to, sells it on the market, and continues to grow Bitcoin, Ethereum, and others. And while you may take a long time to dig up cryptocurrency, HIVE stock is really, really fast at it.

In fact, HIVE stock recently announced it achieved its goal of achieving one exahash in Bitcoin mining. The hash rate is the speed of a computer taking in information and turning it into letters, numbers, or symbols, known as a “hash.” The combined hash speed for HIVE stock is therefore one quintillion hashes per second.

But it’s not stopping there. HIVE stock aims to achieve over three exahashes by the end of fiscal 2022, which will also include Ethereum. This is helped by adding almost two thousand miners across the country, and from the more chips and equipment from global shortages and COVID-19 related problems.

The numbers

All this is super interesting and pretty fun to read about, but what about the numbers themselves? That’s the issue here. Investors haven’t received a financial update from the company since December 2020. But if we look at its share growth along with Ethereum and Bitcoin, we can get some idea of where it’s headed. And indeed, the company is doing well, listing on the Nasdaq back in July.

The company has taken on more and more cash, adding miners and equipment in the process to take on this current cryptocurrency boom. In the last year, Ethereum has increased by 820% and Bitcoin by 343%. In that time, HIVE stock has also increased by 838%, quite the feat!

In the case of HIVE stock, it does provide investors with at least an investment option into the biggest cryptocurrency options out there. And given that it’s tied to these booming sectors and for such a cheap share price, it might be a good idea to take a small stake.

So the option is up to you. But whether HIVE stock will boom or bust, only time will tell.

Fool contributor Amy Legate-Wolfe has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned.

More on Tech Stocks

telehealth stocks
Tech Stocks

Well Health Stock: Buy, Sell, or Hold In 2026

Down over 50% from all-time highs, Well Health stock offers significant upside potential to shareholders in December 2025.

Read more »

container trucks and cargo planes are part of global logistics system
Stocks for Beginners

TFSA: 3 Premier Canadian Stocks for Your $10,000 Contribution

Invest in your future with high quality Canadian stocks for your TFSA. Discover three stocks offering significant growth potential.

Read more »

Female raising hands enjoying vacation, standing on background of blue cloudless sky.
Tech Stocks

If You Were Waiting for Tech Stocks to Go on Sale, Now’s Your Chance

Tech stocks, like Constellation Software (TSX:CSU), might be terrific bargains amid volatility.

Read more »

visualization of a digital brain
Tech Stocks

The AI Stocks I’m Seriously Considering After the Tech Wreck

Shopify (TSX:SHOP) stock is a seriously impressive stock that just had a great Black Friday.

Read more »

Engineers walk through a facility.
Tech Stocks

TFSA Investors: How to Invest $7,000 in 2026?

TFSA investors should consider investing in diversified index funds and undervalued growth stocks to derive inflation-beating returns.

Read more »

gift is bigger than the other
Tech Stocks

1 Oversold TSX Tech Stock to Buy and Hold in December 2025

Down almost 55% from its 52-week high, CMG is a TSX tech stock that offers significant upside potential in December…

Read more »

Business success of growth metaverse finance and investment profit graph concept or development analysis progress chart on financial market achievement strategy background with increase hand diagram
Dividend Stocks

This Under-the-Radar Tech Stock Can Be Canada’s Next Unicorn

This under-the-radar Canadian power-tech supplier rides AI data centres and electrification, and could quietly compound into a unicorn.

Read more »

investor looks at volatility chart
Tech Stocks

This Soaring Canadian AI Stock Still Trades at a 33% Discount in December 2025

Down 14% from all-time highs, Celestica is an AI stock that trades at a discount to consensus price targets in…

Read more »